Rialto Wealth Management LLC bought a new position in shares of Danaher Co. (NYSE:DHR – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 149 shares of the conglomerate’s stock, valued at approximately $34,000.
Other institutional investors also recently bought and sold shares of the company. Heck Capital Advisors LLC bought a new position in shares of Danaher during the 4th quarter valued at about $27,000. Decker Retirement Planning Inc. purchased a new stake in shares of Danaher in the fourth quarter worth about $31,000. Golden State Wealth Management LLC bought a new position in Danaher during the fourth quarter valued at approximately $31,000. Strategic Financial Concepts LLC purchased a new position in Danaher during the 4th quarter valued at approximately $31,000. Finally, Pineridge Advisors LLC increased its stake in Danaher by 63.3% in the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after acquiring an additional 57 shares during the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.
Insider Activity at Danaher
In other news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 11.10% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
View Our Latest Report on Danaher
Danaher Trading Down 1.1 %
Shares of DHR opened at $212.35 on Monday. The firm has a market capitalization of $151.77 billion, a price-to-earnings ratio of 40.22, a PEG ratio of 2.66 and a beta of 0.82. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. Danaher Co. has a 1-year low of $196.80 and a 1-year high of $281.70. The company has a 50-day moving average of $222.51 and a 200 day moving average of $242.62.
Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period last year, the business earned $2.09 earnings per share. On average, research analysts expect that Danaher Co. will post 7.63 EPS for the current year.
Danaher Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.32 per share. The ex-dividend date is Friday, March 28th. This represents a $1.28 annualized dividend and a dividend yield of 0.60%. This is a positive change from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio (DPR) is currently 24.24%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More
- Five stocks we like better than Danaher
- 3 Dividend Kings To Consider
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- What to Know About Investing in Penny Stocks
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- How to Most Effectively Use the MarketBeat Earnings Screener
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.